Kyle Bake

Kyle Bake has extensive experience in the field of scientific research and development. Kyle started their career as a Research Engineer at Schlumberger in June 2010 and worked there until May 2020. During their tenure, they gained valuable knowledge and skills in research engineering.

In December 2020, they joined Intellia Therapeutics, Inc. as a Senior Associate Scientist. Kyle held this position until January 2022, during which they utilized their expertise in LNP formulation and analytics, mRNA purification and analytics, and guide RNA purification and analytics. Subsequently, they were promoted to the role of Scientist, where they continued to contribute to the company's scientific advancements in these areas until June 2023.

Currently, Kyle works as a Principal Scientist at Orna Therapeutics, a position they started in June 2023. Kyle'sexpertise and experience in scientific research make him a valuable asset to the company as they aim to develop innovative therapies.

Kyle Bake obtained a Master's degree in Chemistry from Tufts University in the year 2009.